ESC & iPSC News 12.07 March 1, 2017 | |
| |
TOP STORYBy generating human induced pluripotent stem cells (hiPSCs) from craniofrontonasal syndrome patients, researchers demonstrated that mosaicism for EPHRIN-B1 expression induced by random X inactivation in heterozygous females results in robust cell segregation in human neuroepithelial cells. [Stem Cell Reports] Full Article | |
| |
PUBLICATIONS(Ranked by impact factor of the journal)Scientists report the correction of Huntington disease (HD) human induced pluripotent stem cells (hiPSCs) using a CRISPR-Cas9 and piggyBac transposon-based approach. They showed that both HD and corrected isogenic hiPSCs can be differentiated into excitable, synaptically active forebrain neurons. [Stem Cell Reports] Full Article | Graphical Abstract Scientists generated nuclear-transfer ES (ntES) cells from both MEFs and tail-tip fibroblasts and by whole genome sequencing found fewer mutations compared with iPSCs generated by retroviral gene transduction. [Stem Cells] Abstract The authors studied the effects of E2 on dopamine (DA) neuron induction of human embryonic stem cells (hESC) and its related signaling pathways using a three-stage protocol. The population of hESC-derived neural precursor cells and DA neurons was increased to 92% and 93% to that of DMSO group, respectively. [J Cell Mol Med] Full Article Resveratrol Enhances Self-Renewal of Mouse Embryonic Stem Cells Researchers investigated the function of resveratrol (RSV) in self-renewal of mouse embryonic stem cells (ESCs) and the related mechanisms. In contrast with its reported roles, they found unexpectedly that differentiated ESCs or iPSCs treated by RSV would not show further differentiation, but regained a naïve pluripotency state with higher expressions of core transcriptional factors and with the ability to differentiate into all three germ layers when transplanted in vivo. [J Cell Biochem] Abstract Using mouse kidney extracellular matrix and mouse embryonic stem cells the authors report that the extracellular matrix can support the development of kidney structures if the stem cells are first differentiated to kidney progenitor cells before being applied to the acellular organ. [Stem Cell Rev] Full Article The objective of this study was to determine the transcriptomic profile related to bovine pluripotency. In vitro derived embryos were cultured in various culture media that recently have been reported capable of maintaining the naïve pluripotent state of human embryonic cells. Compared to standard culture conditions, embryo cultured in ‘naïve’ media reduced mRNA expression levels of the key pluripotency markers NANOG and POU5F1. [PLoS One] Full Article Investigators generated induced pluripotent stem cells (iPSCs) from idiopathic Parkinson’s disease (PD) patients and found that there was no significant vulnerability between dopaminergic (DA) neurons generated from healthy individuals and idiopathic PD patients. PDiPSC-derived DA neurons survived and functioned in the brains of PD model rats. [J Neurosci Res] Abstract Scientists describe the derivation, pluripotency, differentiation and growth responses of embryonic stem (ES) cell lines from Nile tilapia, a world-wide commercial farmed fish. One representative line, TES1, showed stable growth and phenotypic characteristics of ES cells over 200 days of culture with more than 59 passages under feeder-free conditions. [Dev Growth Differ] Abstract Feeder-Independent Canine Induced Pluripotent Stem Cells Maintained under Serum-Free Conditions The authors generated canine induced pluripotent stem cells (ciPSCs) expressing doxycycline-inducible murine Oct3/4, Sox2, Klf4, and c-Myc, which were introduced using lentiviral vectors. The resultant ciPSCs required doxycycline to proliferate in the undifferentiated state. [Mol Reprod Dev] Abstract | |
| |
REVIEWSp53 Switches Off Pluripotency on Differentiation The role of p53 as “a guardian of the genome” has been well established in somatic cells. However, its role in pluripotent stem cells remains much more elusive. The authors discuss research progress in understanding the role of p53 in pluripotent stem cells and in pluripotent stem cell-like cancer stem cells. [Stem Cell Res Ther] Full Article Visit our reviews page to see a complete list of reviews in the ESC & iPSC research field. | |
| |
INDUSTRY NEWSRegulator Ready Stem Cell Lines Now Available for Clinical Development The UK Stem Cell Bank at the National Institute for Biological Standards and Control is releasing its first stem cell lines suitable for development into novel cell-based medicines to researchers wishing to bring new and innovative therapies to clinical trial. [Medicines and Healthcare products Regulatory Agency] Press Release ViaCyte, Inc. and Beyond Type 1 announced a grant from Beyond Type 1 to support ViaCyte’s efforts to develop a functional cure for type 1 and other insulin-requiring diabetes. The company’s pluripotent stem cell-derived islet cell replacement therapy, the PEC-Direct™ product candidate, has the potential to be a breakthrough treatment for high-risk type 1 diabetes. [ViaCyte, Inc.] Press Release | |
| |
POLICY NEWSPeer-Review Activists Push Psychology Journals towards Open Data An editor on the board of a journal published by the prestigious American Psychological Association has been asked to resign in a controversy over data sharing in peer review. Gert Storms — who says he won’t step down — is one of a few hundred scientists who have vowed that, from the start of this year, they will begin rejecting papers if authors won’t publicly share the underlying data, or explain why they can’t. [Nature News] Editorial Senior Republican Lawmaker Has Some Advice for U.S. Science Marchers The chairman of a congressional spending panel that oversees a wide swath of U.S. science agencies has some unusual advice for scientists planning to march on 22 April: Don’t talk about research. Instead, demand that Congress find a way to cut mandatory spending programs. [ScienceInsider] Editorial UK Scientists Welcome Changes to Controversial Research Reforms Amendments aim to protect autonomy and the independence of research funders from political interference. [Nature News] Editorial
| |
EVENTSNEW International Society for Cellular Therapy (ISCT) 2017 Visit our events page to see a complete list of events in the community.
| |
JOB OPPORTUNITIESNEW Senior Scientist – Stem Cell Gene Editing (Universal Cells) NEW Postdoctoral Fellow – Stem Cell Research (Ecole Polytechnique Fédérale de Lausanne) Research Associate – Bioengineering (STEMCELL Technologies, Inc.) Research Associate – Research and Development (STEMCELL Technologies, Inc.) Postdoctoral Position – RNA, Stem Cell and Cancer Biology (Lund University) PhD Student – Epigenetics (Institut of Molecular Biology) Postdoctoral Fellow – Human Genome Editing (Johns Hopkins University School of Medicine) Postdoctoral Position – Cellular Genetics (Wellcome Trust Sanger Institute) Postdoctoral Fellow – Multiple Areas (University of Oklahoma) Assistant or Associate Member – Stem CellGene Therapy (Fred Hutchinson Cancer Research Center) Postdoctoral Fellow – Pluripotent Stem Cell Technology (University of California, Davis) Recruit Top Talent: Reach potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.
| |
Have we missed an important article or publication in ESC & iPSC News? Click here to submit! Comments or suggestions? Submit your feedback here. | |
|
Home ESC & iPSC News Volume 12.08 | Mar 1 2017